PG
Therapeutic Areas
Biomerica Pipeline
| Drug | Indication | Phase |
|---|---|---|
| inFoods® IBS Test | Irritable Bowel Syndrome (IBS) - Food Trigger Identification | Commercial |
| ACTH ELISA | Endocrine Disorders (Adrenocorticotropic Hormone) | Commercial |
| Allerquant™ 14G A ELISA | Food Intolerance / Allergies | Commercial |
| Allerquant™ 14G B ELISA | Food Intolerance / Allergies | Commercial |
| Allerquant™ 42G ELISA | Food Intolerance / Allergies | Commercial |
| Allerquant™ 45G ELISA (General Panel) | Food Intolerance / Allergies | Commercial |
| Allerquant™ 7G A ELISA | Food Intolerance / Allergies | Commercial |
| Allerquant™ 7G B ELISA | Food Intolerance / Allergies | Commercial |
Leadership Team at Biomerica
ZI
Zack Irani
Chief Executive Officer (CEO)
GL
Gary Lu, CPA
Chief Financial Officer (CFO)
SM
Scott Madel
Chief Commercial Officer (CCO)
BQ
Bonnie Qiu, M.Sci.
Senior Director of Quality Assurance & Regulatory Affairs
AS
Astrid Starke, PhD
Director of Marketing
LL
Lucy Liu, PhD
Director of Manufacturing & Technical Operations
CL
Christiane Loose
Director of Sales (Europe & South America)
AB
Allen Barbieri
Executive Vice Chairman (Board of Directors)
EB
Eric B. Chin
Independent Director
JE
Jane Emerson, MD, PhD
Independent Director